Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-31

FDA Approved: SAXAGLIPTIN — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a new original ANDA for saxagliptin from Aurobindo Pharma Limited, providing a generic version of the diabetes medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Saxagliptin (saxagliptin)

Snippet

ORIG AP for SAXAGLIPTIN (SAXAGLIPTIN)